Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

View 0 Studies Requested

Pilot Study of EGFR Inhibition with Erlotinib in Cirrhosis to Inhibit Fibrogenesis and Prevent Hepatocellular Carcinoma

Enrollment Statistics

Target Enrollment: 65

Actual Enrollment: 46

Actual Registration: 65

  • 65 were evaluated for eligibility
    • 19 were excluded for not meeting inclusion/exclusion criteria
    • 46 were registered for 7 days of daily erlotinib
      • 23 completed study
      • 20 were Ineligible (includes screen failures)
      • 1 withdrew due to adverse events
      • 1 died
      • 1 Physician decision

Participant Statistics

  • Age
    • Mean: 59
    • Median: 60
    • Range: 28-81
  • Sex
    • Female: 15 (32.6%)
    • Male: 31 (67.4%)
  • BMI
    • Mean: 34.4
    • Median: 27.4
    • Range: 18.5-48.6, (135.3)